Boron neutron capture therapy shows high response but limited durability in head and neck cancer
In 285 mostly preirradiated patients, BNCT achieved 80.4% objective response, 41.5% two-year local control, and 2.1% grade 5 toxicity.
In 285 mostly preirradiated patients, BNCT achieved 80.4% objective response, 41.5% two-year local control, and 2.1% grade 5 toxicity.
From 2015 to 2025, target coverage, dose fall-off and OAR sparing improved, while mean reirradiation target volume simultaneously decreased by 64%.
A head-and-neck-trained diffusion transformer generalized proton dose denoising across three unseen sites, but optimized Gaussian filtering matched or outperformed several global metrics.
Daily online adaptation improved target coverage in 76% of fractions, while OAR effects were mixed and RTT-only delivery remained feasible.
Urinary microRNA profiles changed during prostate MR-SBRT and differed between patients with and without early grade ≥2 urinary toxicity.
Reducing breast CBCT acquisition from 200° to 120° maintained submillimeter average registration differences while reducing central imaging dose by 33%.
Gynecologic online ART added 13.7 minutes from adaptation start to plan approval, with contour editing and optimization consuming 71% of that time.
Across 137 studies, specific cardiac substructures repeatedly showed dose–toxicity relationships, while evidence linking radiation-induced cardiac injury directly to survival remained limited.
One-third of patients developed malnutrition during nasopharyngeal RT, while prophylactic enteral nutrition was associated with better post-treatment weight stabilization.
Only 36 carbon-ion studies were open to enrollment worldwide, with most early-phase and 21 concentrated at three centers.
Across more than 215,000 delivered beams, a compact proton system maintained high throughput despite smaller fields and frequent couch flips.
Excision followed by HDR brachytherapy within six hours achieved 92.2% local control with only mild late toxicity in 64 keloids.
MRI-linac R2* mapping detected transient prostate and tumour changes after two SABR fractions, supporting feasibility but not yet biomarker validity.
Re-irradiation plus regional or capacitive hyperthermia achieved 94% complete response across 17 breast cancer recurrences with no grade ≥3 toxicity.
Pre-treatment physicist consultation was associated with higher EPID gamma passing rates and smaller setup shifts during breast radiotherapy.